Jump to content

Search the Community

Showing results for tags 'EIW2016'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Discussions
    • Polio
    • Flu awareness
    • European Immunization Week, 23–29 April 2018
    • Migration and immunization
    • World Hepatitis Day, 28 July 2017
    • European Immunization Week, 24 - 30 April 2017
    • General discussions
    • Education on Immunization
    • Data visualization
    • About NITAGs
    • Research papers, articles, and reports
    • News and social media
    • Updates from partners and stakeholders
    • European Immunization Week (2016)
    • Job opportunities
    • Q&A about the site
    • Innsbruck Treffen (private forum)

Categories

  • European Immunization Week 2018
    • Planning resources - EIW 2018
    • Brochures - EIW 2018
    • Infographics - EIW 2018
    • Posters - EIW 2018
    • Banners and social media - EIW 2018
    • Meeting folders - EIW 2018
  • Flu Awareness - 2017
    • Flu Awareness Campaign Posters
  • European Immunization Week 2017
    • Planning resources - EIW 2017
    • Brochures - EIW 2017
    • Infographics - EIW 2017
    • Posters - EIW 2017
    • Banners and social media - EIW 2017
    • Meeting folders - EIW 2017
  • Flu Awareness - 2016
    • Flu Awareness Campaign Posters
  • EIW 2016
    • Planning resources
    • Posters
    • Meeting folders

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


About Me


Gender


Location


Country


Zip

Found 35 results

  1. Version 1.0.0

    37 downloads

    Download EIW 2016 communications package in Russian (Pусский)
  2. Version 1.0.0

    69 downloads

    Download the EIW 2016 communications package in English.
  3. Azerbaijan is among the 21 Member States of the WHO European Region that eliminated endemic transmission of measles, and one of the 20 that eliminated endemic transmission of rubella as of 2014. Azerbaijan utilized European Immunization Week not only to highlight its measles and rubella elimination status, but also to proactively address the Regional Verification Commission’s recommendations for the country to maintain elimination. Read more: http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/news/news/2016/04/european-immunization-week-in-azerbaijan-dedicated-to-maintaining-progress-in-disease-prevention
  4. We launched a crossword to draw the attention of health care workers to EIW: http://impfbrief.de/index.php?nav=5#id202 crossword (in German): https://www.xwords-generator.de/de/s/emp74 crossword generator: https://www.xwords-generator.de Has anybody else a similar idea? We would like to try more approaches of this kind.
  5. EIW 2016 activities in the Tyrol region, Austria. Submitted by: Peter Kreidl, University of Innsbruck. https://www.i-med.ac.at/tirol-masern/
  6. In this interview with Vaccines Today, Robb Butler, Programme Manager of the Vaccine-preventable Diseases and Immunization programme of the WHO Regional Office for Europe, explains why things are looking up for measles and rubella elimination in the Region and what needs to be done to finish the job: http://www.vaccinestoday.eu/vaccines/measles-and-rubella-elimination-gaining-momentum/?platform=hootsuite
  7. Thirty-two countries in the European Region have interrupted transmission of endemic measles and/or rubella as of 2014, according to the conclusions of the European Regional Verification Commission for Measles and Rubella Elimination (RVC). Azerbaijan is among those countries that have sustained interruption for a period of three years and are therefore considered to have eliminated measles and rubella. This progress and momentum toward elimination in the entire European Region will be the focus of European Immunization Week, taking place 24-30 April. Interruption of transmission in more than half of Europe’s countries shows that regional elimination of measles and rubella is possible and we are on the right track to achieve it. Momentum must be maintained to sustain this achievement where it is still fragile, and to ensure the remaining endemic countries catch up quickly. Read the full update on the UN in Azerbaijan website.
  8. I’m Sabrina Bacci, an expert in vaccine preventable disease surveillance at the European Centre for Disease Prevention and Control (ECDC). The postings on this site are my own and don't necessarily represent ECDC positions or opinions. We are all familiar with going to the doctor or to a vaccination clinic and being immunised against a disease. This is the final step of a long process which involves vaccine development (a process that lasts in the range of 10 years before a vaccine is placed on the market and includes many studies), disease monitoring (also called routine surveillance), monitoring of the vaccination programme itself, and monitoring vaccine safety. This blog briefly explains the monitoring of vaccination programmes. Monitoring vaccination programmes is done through specific studies which might involve different aspects: collecting information on vaccine effectiveness (how the vaccine is performing in individuals) and estimating the impact of a vaccination programme in society. Vaccine effectiveness studies measure how well a vaccine works at the individual level when introduced into society. In addition, this type of study may bring evidence that less/more doses are needed to confer protection in the long term and that a vaccine protects individuals from additional diseases than those it was initially created for. The impact of a vaccination programme can be studied by comparing different populations with different programmes. For the same vaccine it is possible that different countries implement different strategies, for example targeting different age groups (adults over age 55 or adults over age 65), or different risk groups. Studies of vaccine effectiveness and impact are complex and need to be designed with appropriate methodologies and high quality data. One example of a study aimed at monitoring both the effectiveness and impact of vaccination is Pertinent (Pertussis in Infants European Network), a study funded by ECDC in which 9 different countries and approximately 50 hospitals participate. This type of study, by having specific hospitals and dedicated people committed, will contribute to fine tune vaccination programmes with in depth information that is not often available by routine surveillance. When hospitals and local healthcare workers are committed to a specific study, we have good confidence that high quality information will be collected in addition to the “routine” daily information reported by all physicians in the country. However both aspects are important and complementary. Studies on monitoring vaccination programmes are an essential aspect of the long journey of vaccines and they complement information derived from other sources. They have contributed and continue to contribute to ensuring the effective and appropriate use of vaccines.
  9. Produced by the Split county institute of public health and distributed during EIW 2016.
  10. Produced by the Split county institute of public health and distributed during EIW 2016.
  11. I’m a Senior Expert in Capacity Building and Communication, working at the European Centre for Disease Prevention and Control (ECDC). The postings on this site are my own and don't necessarily represent ECDC’s positions or opinions. The other day I was at a crossroad in the beautiful city of Stockholm and the traffic light was red; I was wondering if I should cross or not as no cars were coming. And by the way crossing a street on red seems acceptable in Sweden. While I had this debate with myself I also used the wording – why am I so hesitant? And that was the trigger to the next thought – I am hesitant myself. I was actually concerned with the potential consequences of crossing the street on red light. Wouldn’t you be too? It is fair to say that we all have our concerns, are hesitant at some point in time. For me though hesitancy related to vaccination represents something more than these “little concerns” we have in our lives everyday, it is about when people have a deeper concern might hamper their positive attitude and stop them to vaccinate. This is of course my own interpretation of the definition provided by the Strategic Advisory Group of Experts (SAGE) on Immunisation1. In the context of an ECDC project, the London School of Hygiene and Tropical Medicine (LSHTM) carried out a small qualitative study to look at the opinions of healthcare workers to vaccination. The study addressed primary healthcare practitioners in four countries of the European Union, working in areas with low vaccine coverage. Although clearly not representative, a key conclusion is that physicians do have concerns, some of them being hesitant to vaccination because, among other reasons, they feel responsible if something happens to their patients. As a person who made the Hippocratic Oath when graduating from the Faculty of Medicine I would share the feeling of being responsible and wanting the best for my patients. So what can we, the public health community, do in order to better equip our fellow colleagues in dealing with their concerns and serving better their patients? I would say inform, inform, inform. In these times when the Internet and social media are widely used as sources of information (and not always the correct information) for everybody, I consider we have the responsibility to engage and inform, inform, inform – correct information, from trustworthy sources. ECDC has recently published relevant documents including communication tools in this area aimed at primary healthcare and public health professionals. You can read more about the ECDC work at: Technical reports: Vaccination motivating hesistant populations europe literature review Vaccine hesitancy among healthcare workers Communication guides: Lets talk about protection vaccination guide Lets talk about hesitancy vaccination guide Translation is not enough 1 Vaccine hesitancy is defined as ‘a behaviour, influenced by a number of factors including issues of confidence (level of trust in vaccine or provider), complacency (do not perceive a need for a vaccine, do not value the vaccine), and convenience (access). Vaccine-hesitant individuals are a heterogeneous group that are indecisive in varying degrees about specific vaccines or vaccination in general. Vaccine-hesitant individuals may accept all vaccines but remain concerned about vaccines, some may refuse or delay some vaccines, but accept others, and some individuals may refuse all vaccines’.
  12. Denmark: Uge 17 - 2016 - EPI-NYT - Statens Serum Institut I denne uge markerer WHO for 11. gang European Immunization Week. WHO ønsker at sætte fokus på vaccinationer som et effektivt middel til at forebygge ... Azerbaijan: WHO recognizes Azerbaijan as a country which completely eliminated measles and rubella... According to the UN, to date 32 countries in the European region have ... be the center of attention of the European Immunization Week, running on 24-30 April. Russia: 2-3 severe cases of post-vaccination complications reported n Tatarstan among children over 10 years - epidemiologist It was announced today at a press conference at Tatar-Inform news agency, dedicated to the European Immunization Week in Tatarstan by Head of the Republic ... Parents Urged To Vaccinate Against Measles, Mumps, Rubella As 24000 Kids Aren't Immunised Each Year Huffington Post UK The call to get vaccinated coincides with European Immunisation Week, run by the World Health Organisation with the theme “close the immunisation gap”. Measles is a “highly infectious viral illness” that can be very unpleasant and sometimes lead to ...
  13. In their joint statement on the occasion of European Immunization Week, the WHO Regional Director and HRH Princess Crown Princess of Denmark, Patron of the Regional Office for Europe, together called on Member States to identify new ways to measure and communicate the full impact and value of vaccination.
  14. Many activities were organized in Austria, including an awareness raising campaign about measles using a classic car.
  15. Many activities were organized in Austria, including an awareness raising campaign about measles using a classic car.
  16. "Talkshow" with different experts and vaccine opponents performed by junior high school students in Ludwigsburg, Germany. The 35min play was followed by a discussion forum in front of approximately 150 students and several teachers.
  17. Electronic immunisation registers – Making a difference Electronic immunisation registers are not panacea to measles elimination but they could make a difference. Measles incidence fell 73% worldwide between 2000 and 2014, from 146 to 40 cases per million population, and eradication now looms in the distance. But for decades, measles control has stalled here in Europe and we just missed yet another elimination target date. The truth is that we are in desperate need of innovation, renewed commitments and a change of tactics when it comes to measles control in Europe. Unless we do some things better and others differently, Europe is unlikely to break the chain of domestic transmission any time soon. More of the same will not graduate Europe to join the measles-free part of the world. Data for decision-making is critical and timely, accurate and detailed information on vaccination uptake over time and place is of the essence for responsive immunisation programme management. Electronic Immunisation Registers (EIR) and Immunisation Information Systems (IIS) are two commonly used terms for computerised systems that record individual vaccinations. Such systems allow managers to monitor vaccine uptake at high resolution (i.e. uptake in smaller administrative areas), rapidly investigate signals of adverse events from vaccination, and study changes in vaccine effectiveness. Web-based EIR and IIS allow for real-time recording of individual vaccinations, including bar-code identification of the unique vaccine vial that was administered to a particular recipient. The advantages for parents and others are substantial: they no longer have to safe-guard paper records of vaccinations, they can receive verified transcripts of register records on request when required by schools and employers, and they have access to a trusted source of information on vaccines and vaccination schedules. If electronic immunisation registers offer such clear benefits to both parents and programme managers, then why do not all countries in Europe invest in them? Is it because national immunisation programmes have become complacent as a result of their historic successes? Are public health managers a conservative community that worries about rocking the boat? Or are there other, more palpable challenges of a financial, technical or legislative nature that have delayed these digital developments? I would like to learn more about your opinions on this matter. And I encourage you to explore the Norwegian electronic immunisation register as an example of what a register can deliver. This database has national coverage, operates with unique personal identifiers, and covers all children in the country. Immunisation registers such as the Norwegian that are populated from birth registration and migration records produce near complete denominators, an invaluable asset for surveillance of vaccine safety and effectiveness, and a fantastic resource for programme managers. The immunisation register in Norway is called SysVak. Click on the link to find out what SysVak offers to parents and individual vaccine recipients (information available in English). Uptake of the childhood vaccination programme is reported in absolute numbers and percentage fully vaccinated children at ages 2, 9 and 16 years, and down to the level of communes. Check out the interactive database on vaccination uptake by place, year and vaccine: http://www.norgeshelsa.no/norgeshelsa/ Systems similar to the Norwegian are in operation in other European countries, including Denmark, Finland, UK, and the Netherlands. The European Centre for Disease Prevention and Control (ECDC) recently started a project aimed at sharing experiences and expertise on IIS, and to provide technical support to countries with plans to set up electronic immunisation registries. If you want to learn more about this project please send an email to info@ecdc.europa.eu. To share your thoughts on electronic immunisation registers you can join the conversation by posting a comment here.
  18. World Immunisation Week special blog: What Europe can learn from North America - Addressing Adult Immunization with the Same Passion as the Paediatric Program On an almost daily basis there is a media story discussing an outbreak of a vaccine-preventable disease in a paediatric patient population. Healthcare professionals, public health officials and parent groups are commonly quoted regarding the negative impact of low immunization rates and vaccine exemptions on public health. Governments and public health in most countries have media campaigns on the importance of immunization in children and most healthcare professionals actively promote immunization through the first 18 years of life. But something happens when our patients reach their 18th birthday. Full article on European ADULT IMMUNISATION HUB
  19. Message for European Immunization Week by Vytenis Andriukaitis, Commissioner for Health and Food Safety. The original article published 26 April 2016 on: European Commission, Vytenis Andriukaitis Blog Vaccination: a health-protecting and life-saving gift for all of Europe's children This week (25 to 30 April) is European Immunisation Week, which gives health advocates like myself the opportunity to promote the importance of vaccination for every child. As a medical doctor by profession, I can say with conviction that vaccination programmes are one of the greatest achievements of public health. They have contributed to the eradication of polio and smallpox in the EU and led to a significant decline in a number of other infectious diseases. ‘Herd immunity’ is dependent on a high rate of vaccination coverage, and I am therefore concerned by the rise in vaccine scepticism, which has led to some parents refusing or delaying vaccines for their children. To date, vaccine coverage remains relatively high in the EU. We must, however, keep a watchful eye and work together to raise awareness on the importance of vaccination and correct misconceptions. Although vaccination is the in hands of the Member States, the Commission has a role to play supporting the countries in maintaining or increasing vaccination against a range of vaccine-preventable diseases. I am committed to stepping up EU support for national efforts through, for example, facilitating the sharing of data and exchange of best practice, providing technical support to national public health campaigns, and providing tools and scientific advice. We are already working with Member States in the Health Security Committee to address vaccine needs related to shortages and also to examine possible options to address current vaccine needs, in particular for most vulnerable groups, such as infants and children. We also support Member States in their efforts to address vaccine shortages on a longer term by exploring options such as a voluntary mechanism for sharing vaccines in case of urgent need. We also need more research and innovation not only to develop new vaccines but also to monitor the impact of vaccination, assess the effectiveness of risk communication and develop a life-course approach to vaccination. We are working on this hand in hand with Member States. In addition, I strongly encourage Member States to make use of the Joint Procurement mechanism. Twenty-four of them have now signed a Joint Procurement Agreement that enables them to buy medicines - including vaccines - together at better conditions. Although I am an advocate for vaccination 52 weeks of the year, this week my message is especially loud and clear: All children and adults in Europe, whether they were born here or have recently arrived, deserve the health protecting and life-saving gift of vaccination! For more information: http://ec.europa.eu/health/vaccination/policy/index_en.htm
  20. I’m Robert Whittaker, a scientific officer in vaccine preventable disease surveillance at the European Centre for Disease Prevention and Control (ECDC). The postings on this site are my own and don't necessarily represent ECDC positions or opinions. We live in an age where information is easier to share and has a wider reach than ever before. At the click of a button we can rapidly send and receive information on anything from an unfolding measles outbreak to just what we had for lunch. As part of the continuing fight to prevent and control vaccine preventable diseases, it is important that both the scientific community and the general public have access to relevant and reliable information. It must be timely, easy to find and clear and simple to understand. This is essential to help maintain public confidence in vaccination, ensure the best allocation of resources, promote immunisation, increase the knowledge and understanding of vaccine preventable diseases and improve vaccination coverage rates. In order to improve the access, timeliness of publication and display of European surveillance data on infectious disease, ECDC has developed the Surveillance Atlas of Infectious Diseases. This is a publically available and interactive on-line tool that allows users to freely ask and get an immediate answer to their questions on the who, what and when of different diseases across the European Union. Users can interact and manipulate the data at their leisure using maps, diagrams, time series, distributions and tables for a range of both standard and disease-specific indicators, designed to make the best use of the data available. It can be accessed by clicking on the link above, or under ‘Data & Tools’ on the ECDC website. The tool was first launched in 2014 with three pilot diseases: tuberculosis, invasive Haemophilus influenzae disease and invasive meningococcal disease. During European Immunisation Week 2015, atlas pages for measles and rubella were added. In January 2016, surveillance data for four new vaccine preventable diseases were made available through this tool: mumps, pertussis, tetanus and invasive pneumococcal disease. In addition, all diseases have been updated to include data up to at least 2014. Historical data are also included and some disease have data available going back to 1996. In short, this is the most comprehensive collection of European surveillance data on vaccine preventable disease ever published in one place. All vaccine preventable diseases now available in the Surveillance Atlas are listed below*; · Measles · Rubella · Mumps · Pertussis · Tetanus · Invasive pneumococcal disease · Invasive Haemophilus influenzae disease · Invasive meningococcal disease · Tuberculosis * Overall, there are currently 31 different diseases available in the Surveillance Atlas of Infectious Diseases So whether you are interested in the situation today or many years ago, in Portugal or Latvia, in infants or the elderly, you can find everything you need in this one-stop shop, just at the click of a button. The development of the Surveillance Atlas tool will continue, with the measles and rubella atlases updated monthly, while all other vaccine preventable diseases are updated annually. In 2016, we also hope to add atlas pages for both diphtheria and polio, as well as new indicators for the currently available vaccine preventable diseases. Watch this space, and if you have any questions or comments related to this project, we would love to hear from you. Please feel free to contact myself at Robert.Whittaker@ecdc.europa.eu or my colleague Sabrina at Sabrina.Bacci@ecdc.europa.eu. You can also send an email to info@ecdc.europa.eu for more information.
  21. Campaign 'Protect, Prevent, Vaccinate to Mark European Immunization Week in Macedonia April 24, 2016 Activities that are part of the campaign 'Protect, Prevent, Vaccinate!' are taking place at the Skopje Zoo on Sunday, organized by the Healthcare Ministry and the Skopje-based and national Public Health Institutes, in the aim of marking the European Immunization Week. - See more at: http://www.independent.mk/articles/30941/Campaign+'Protect,+Prevent,+Vaccinate+to+Mark+European+Immunization+Week+in+Macedonia#sthash.Kv8NPubi.dpuf Photos from the day available here.
  22. Deutsche Welle, 24 April: The world is filled with nasty, but preventable, illnesses, some of which can cause disability or even death: human papillomavirus (which can lead to cervical cancer), diphtheria, hepatitis B, measles, mumps, pertussis (whooping cough), pneumonia, polio, rotavirus, rubella and tetanus. During World Immunization Week, held from April 24 to 30, the UN's health body wants to remind adults and children that a simple shot can prevent these diseases and many more. To do so, the World Health Organization (WHO) has scheduled a series of regional events and vaccination campaigns to showcase successes and highlight areas where global efforts need to focus. Read the full article
  23. Version 1.0.0

    31 downloads

    EIW 2016 posters in Portuguese. Available as images (for use on screen in jpg format), and PDF file (for print). Note: To download images, click on a screenshot above to open the image, and then right click on the image to save it on your computer. To download the PDF for print, click on the red button on the right 'Download this file'. The PDF file size is 204 Mb. In case of slow internet connection, please allow some time to download.
×
×
  • Create New...